Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Russka ShumnalievaNaveen RJennifer HannahMahnoor JavaidNaitica DarookaDebaditya RoyDaniel E GonzalezTsvetelina V VelikovaMarcin MilchertMasataka KuwanaMasataka KuwanaAbraham Edgar Gracia-RamosPeter BoydPraggya YaadavKaren ChengLinda KobertLorenzo CavagnaParikshit SenJessica A DayAshima MakolCarlos Enrique Toro GutiérrezCarlo V Caballero UribeSreoshy SahaIoannis ParodisDzifa DeyElena NikiphorouOliver DistlerEsha KadamAi Lyn TanSamuel Katsuyuki ShinjoNelly ZiadéJohannes KnitzaGabriela Arredondo Hector ChinoyRohit AggarwalVikas GuptaLatika Guptanull nullPublished in: International journal of rheumatic diseases (2024)
This study reports a low occurrence of new-onset SAIDs following COVID-19 vaccination, primarily IIMs, PMR, and inflammatory arthritis. Identified risk factors included pre-existing AID multimorbidity, mental health diseases, and mixed race. Revaccination was well tolerated by most patients; therefore, we recommend continuing COVID-19 vaccination in the general population. However, long-term studies are needed to understand the autoimmune phenomena arising post-vaccination.